Is Hyaluronic Acid Skin Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Hyaluronic Acid Skin Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - According to Merz scores before and 3 months after treatment, the wrinkles were dramatically reduced in both groups ( p value: p value: 0.633). [Saffarian Z (2026); evidence level 2] - Conclusion We have shown that adding Profhilo to BTX-A injection does not have any short-term clinical or sonographic advantage in frontal area wrinkle reduction. [Saffarian Z (2026); evidence level 2] - Background Hyaluronic acid (HA) and Botulinum toxin A (BTX-A) treatments are highly regarded for their effectiveness in facial rejuvenation. [Saffarian Z (2026); evidence level 2] - Aim To investigate whether adding Profhilo enhances the effects of BTX-A for frontal skin rejuvenation. [Saffarian Z (2026); evidence level 2] - Hydration increased steadily in the treatment group, exceeding that of the control at all post-treatment time points (P Conclusion Full‑face intradermal NCHA improved skin hydration, elasticity, texture, and fine lines with a favorable safety profile. [Cheng H (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.